Picture of Resmed logo

RMD Resmed Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for Resmed, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
2024
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line6224757798981,021
Depreciation
Non-Cash Items12410412092.7159
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-97.91.41-708-46244.8
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Cash from Operating Activities8027373516931,401
Capital Expenditures-106-117-156-134-115
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-73.9-41.6-73.9-1,026-155
Acquisition of Business
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Cash from Investing Activities-180-158-230-1,160-270
Financing Cash Flow Items-46.4-53.7-52.4-33-10.1
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-317-765-128423-1,119
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash316-168-21.6-45.810.5